| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |